Clinical Trial Update: Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis [Phase 4]

View source ↗

Summary

Pfizer completed a Phase 4 trial evaluating the safety and efficacy of anidulafungin (Eraxis) in patients with candidemia or invasive candidiasis, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Eraxis (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidiasis | Phase 4 | Status: COMPLETED | Results posted: 2011-10-03